Article
The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes.
Psychopharmacology - 1 Jun 2015
Jiang Fen, Kim Hae-Deun, Na Han-Sung, Lee Seok-Yong, Seo Doo-Won, Choi Jong-Yeol, Ha Ji-Hye, Shin Hee-Jung, Kim Young-Hoon, Chung Myeon-Woo
Abstract excerpt
RATIONALE: Two biomarkers: concentration ratio of O-desmethylvenlafaxine/venlafaxine and concentration sum of venlafaxine + O-desmethylvenlafaxine were adopted to indicate venlafaxine responses, but neither is validated. OBJECTIVES: To evaluate the ability of two biomarkers in reflecting venlafaxine pharmacokinetic variations, and to further examine their relationship with venlafaxine treatment outcomes. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
